These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 13523)

  • 1. Detection of serum-blocking factors by inhibition of allorosette formation in rats with long-surviving renal allografts following short-term postoperative ALS treatment.
    Lie TS; Kanda M; Kim WI; Oehr P; Holst A; Choi SK; Biersack HJ
    Transplantation; 1977 Jan; 23(1):1-6. PubMed ID: 13523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune status of indefinitely surviving rat renal allograft recipients after short course of ALS-treatment Detection of a serum blocking factor by allorosette formation inhibition test (author's transl)].
    Lie TS; Kanda M; Kim WI; Holst A; Kawamura A; Biersack HJ
    Res Exp Med (Berl); 1976 May; 167(2):171-83. PubMed ID: 10609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of cell-mediated immunity in rats transplanted with kidneys from donors compatible at the major histocompatibility complex.
    Lie TS; Kanda M; Gundermann KJ; Kim BR; Kimura K; Grünn U
    Transplantation; 1979 Jul; 28(1):51-6. PubMed ID: 36693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific unresponsiveness to fully allogeneic kidney allografts in rats induced by procarbazine hydrochloride and antilymphocyte serum.
    Al Mahdi N; Hutchinson IV; Brent L
    Transplantation; 1983 Nov; 36(5):480-5. PubMed ID: 6356511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
    Wang M; Qu X; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1996 Feb; 61(3):458-64. PubMed ID: 8610361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes.
    Majoor GD; Van Breda Vriesman PJ
    Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat. I. Specific prolongation of donor grafts and suppressor factor in the serum.
    Yoshimura N; Matsui S; Hamashima T; Lee CJ; Ohsaka Y; Oka T
    Transplantation; 1990 Jan; 49(1):167-71. PubMed ID: 2301007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is permanent survival of kidney allograft receivers in weak histo-incompatible combinations dependent on enhancement?].
    Kanda M; Oehr P; Choi SK; Kim WI; Lie TS
    Chir Forum Exp Klin Forsch; 1977 Apr; ():264-8. PubMed ID: 376242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: effect of duration of the treatment.
    Ozer K; Oke R; Gurunluoglu R; Zielinski M; Izycki D; Prajapati R; Siemionow M
    Transplantation; 2003 Jan; 75(1):31-6. PubMed ID: 12544867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1992 Oct; 216(4):409-14; discussion 414-6. PubMed ID: 1417190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunologic mechanism following liver transplantation. An experimental study in the rat].
    Lie TS; Galkowska H; Jaeger K; Niehaus KJ
    Langenbecks Arch Chir; 1983; 360(1):17-27. PubMed ID: 6348454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal pancreas allografts for reversal of diabetes in rats. II. Induction of life-term-specific unresponsiveness to pancreas allografts across nonmajor histocompatibility complex barriers.
    Mullen Y; Shintaku IP
    Transplantation; 1982 Jan; 33(1):3-11. PubMed ID: 7039021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of antibody response and prolongation of skin graft survival by multiple blood transfusions in the rat.
    Lenhard V; Renner D; Hansen B; Opelz G
    Transplantation; 1985 Apr; 39(4):424-9. PubMed ID: 3885493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens.
    Shimomura K; Hardy MA; Oluwole SF
    Transplantation; 1995 Oct; 60(8):806-11. PubMed ID: 7482739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
    Fiedor P; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
    Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
    Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolongation of renal allograft survival in the rat by pretreatment with donor antigen and cyclosporin A.
    Homan WP; Williams KA; Millard PR; Morris PJ
    Transplantation; 1981 Jun; 31(6):423-7. PubMed ID: 7020180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.
    Nakafusa Y; Goss JA; Mohanakumar T; Flye MW
    Transplantation; 1993 Apr; 55(4):877-82. PubMed ID: 8475563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
    Ohzato H; Monaco AP
    Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.